FAKTOR-OPTIONSSCHEIN - AMGEN | Real-time Boerse Frankfurt Warrants 12:18:58 20/06/2024 BST | ||
| 3.84 EUR | -0.52% |
|
| Current month | -1.03% | ||
| 1 month | -13.84% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 20/06/24 | 3.84 | -0.52% |
| 19/06/24 | 3.86 | -0.52% |
| 18/06/24 | 3.88 | +3.74% |
| 17/06/24 | 3.74 | +8.41% |
| 14/06/24 | 3.45 | -0.86% |
Real-time Boerse Frankfurt Warrants
Last update June 20, 2024 at 12:18 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB01W3 |
| ISIN | DE000SB01W34 |
| Date issued | 09/06/2020 |
| Strike | 225.4 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.85 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.33 € |
|---|---|
| Lowest since issue | 1.39 € |
| Spread | 0.23 € |
| Spread % | 5.61% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
306
USD
Average target price
316.4
USD
Spread / Average Target
+3.42%
- Stock Market
- Certificates
- Certificat
